VVP
ANIX icon

Venture Visionary Partners’s Anixa Biosciences ANIX Stock Holding History

Venture Visionary Partners’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-450
Closed -$1.38K – 512
2022
Q2 		$1.38K Buy
+450
New +$1.42K ﹤0.01% 1573

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Venture Visionary Partners's ANIX Position: Q3 2022 in Review

Venture Visionary Partners sold out of Anixa Biosciences (ANIX) in Q3 2022, closing a stake of 450 shares — an estimated $1.38K sold.

Venture Visionary Partners first reported a position in ANIX in Q2 2022 and held it in 1 quarter. The position peaked at $1.38K in Q2 2022. 41 funds tracked by Wall St. Rank hold ANIX as of Q3 2022.

  • Venture Visionary Partners reported no remaining Anixa Biosciences position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 450 Anixa Biosciences shares in Q3 2022, an estimated $1.38K.
  • Venture Visionary Partners first reported a position in Anixa Biosciences in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Anixa Biosciences position peaked at $1.38K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.